| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. (AKBA) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. AKBA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.46M | $4.02M | - | |
| CFO | 320.0K | $371.2K | - | |
| Dir | 160.9K | $186.7K | - | |
| Dir | 129.5K | $150.2K | - | |
| VP | 119.0K | $138.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2022 | Dahan Michel59 | SVP, Chief Operating Officer | Sell | 21,533 | $2.17 | $46,637.46 | -1.8% | -82.8% | -57.4% | |
| Mar 1, 2022 | Faulkingham Dell70 | SVP, CCO | Sell | 13,184 | $2.16 | $28,515.49 | -2.7% | -82.8% | -57.4% | |
| Mar 1, 2022 | Hadas Nicole R.60 | SVP, Chief Legal Officer | Sell | 21,062 | $2.17 | $45,615.06 | -1.8% | -82.8% | -57.4% | |
| Mar 1, 2022 | Spellman David A52 | SVP, CFO And Treasurer | Sell | 8,203 | $2.16 | $17,688.59 | -4.0% | -82.8% | -57.4% | |
| Feb 28, 2022 | Cotreau Violetta | SVP, Chief Accounting Officer | Sell | 3,946 | $2.15 | $8,502.84 | -11.9% | -82.9% | -61.0% | |
| Jan 3, 2022 | Cotreau Violetta | SVP, Chief Accounting Officer | Sell | 5,833 | $2.29 | $13,335.40 | -15.0% | -73.1% | -74.6% | |
| Aug 31, 2021 | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 1,042 | $2.83 | $2,948.86 | -0.6% | -10.9% | -87.6% | |
| Jun 7, 2021 | Gilman Steven C70 | Director | Sell | 4,567 | $3.32 | $15,163.35 | -8.7% | -13.4% | -87.5% | |
| Apr 1, 2021 | Faulkingham Dell70 | SVP, CCO | Sell | 952 | $3.40 | $3,236.80 | -0.7% | +13.8% | -79.9% | |
| Apr 1, 2021 | Spellman David A52 | SVP, CFO And Treasurer | Sell | 790 | $3.40 | $2,686.00 | -1.0% | +13.8% | -79.9% |